Health Catalyst acquires Upfront Healthcare for ~$86M net; reports preliminary Q4 & FY2024 results and 2025 guidance

Health Catalyst, Inc.

Upfront acquisition: ~$86M net consideration (cash + ~5.75M shares) plus up to ~$33.4M earn-out; expected Q1 2025 close.
Preliminary Q4 2024 revenue $78.75-79.75M (+6% YoY), Adj. EBITDA $7.9M (10% margin).
Full-year 2024 revenue $305.7-306.7M (+3%), Adj. EBITDA $26.1M (+137%, 9% margin).
2025 guidance: revenue ~$335M (+10%), Adj. EBITDA ~$39M (+49%, 12% margin).
Net new platform clients 21 in 2024 (+91%); 2025 target ~40 (+90%).

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.